Related Experiment Videos
[Propranolol beta-blocker decrease in the concentration of high-affinity binding sites for calcium ions by sarcolemma
Summary
Propranolol inhibits calcium uptake in heart muscle, affecting how hydrocortisone works. This beta-blocker impacts calcium binding directly, unlike glucocorticoids which need intact cells.
Area of Science:
- Pharmacology
- Cardiovascular Physiology
- Cell Biology
Background:
- Isoproterenol stimulates calcium (Ca2+) accumulation in the myocardium.
- Glucocorticoids can potentiate the effects of isoproterenol.
- Understanding the mechanisms of drug action on cardiac calcium handling is crucial.
Purpose of the Study:
- To investigate the in vivo and in vitro effects of propranolol and hydrocortisone on myocardial calcium accumulation.
- To elucidate the role of sarcolemmal calcium binding sites in mediating these effects.
- To differentiate the cellular mechanisms of propranolol and glucocorticoid action.
Main Methods:
- In vivo and in vitro administration of propranolol and hydrocortisone.
- Measurement of 45Ca accumulation in myocardial tissue.
- Assessment of high-affinity calcium binding sites in sarcolemmal membranes.
Main Results:
- Propranolol significantly inhibited isoproterenol-stimulated 45Ca uptake in vivo.
- Propranolol in vitro reduced high-affinity Ca2+ binding sites in sarcolemmal membranes.
- Hydrocortisone's potentiation of isoproterenol was abolished by propranolol in vivo; hydrocortisone did not alter sarcolemmal Ca2+-binding parameters in vitro.
Conclusions:
- Propranolol's in vivo inhibition of catecholamine effects on myocardial calcium likely involves beta-receptor interaction and direct modulation of sarcolemmal calcium binding.
- Glucocorticoid action on calcium handling appears to require intact cellular integrity.
- Propranolol directly alters sarcolemmal calcium binding, independent of glucocorticoid effects in vitro.